Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10884437 | 0.81 | GAA (0.40) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL10937510 | 0.81 | TSHR (0.43) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL4996608 | 0.80 | TSHR (0.36) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL14866067 | 0.77 | EPHX2 (0.34) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL7601706 | 0.77 | HMGCR (0.42) | TSHR | |
| SCHEMBL7112401 | 0.75 | TSHR (0.39) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL13239242 | 0.71 | — | — | |
| SCHEMBL14473468 | 0.69 | ALDH1A1 (0.36) | MGAMGAASIMGAM2 | |
| SCHEMBL2854781 | 0.69 | — | — | |
| SCHEMBL12894891 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117209463-A | Synthetic method of caronic anhydride | 浙江沙星科技股份有限公司 | 2023-12-12 | — | — | CN | claimed |
| CN-117209463-A | Synthetic method of caronic anhydride | 浙江沙星科技股份有限公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-117209463-A | Synthetic method of caronic anhydride | 浙江沙星科技股份有限公司 | 2023-12-12 | — | — | CN | disclosed |
| US-20020161244-A1 | Preparation of cis-6,6-dimethyl-3-oxa-bicyclo(3.1.0)hexan-2-one | LEVIN DANIEL (GB) | 2002-10-31 | — | — | US | disclosed |
| US-6414165-B1 | REACTING LOWER ALKYL ESTER OF 4,5-EPOXY-3,3-DIMETHYLPENTANOIC ACID OR SULFONIC ESTER OF BETA,BETA-DIMETHYL-GAMMA-(HYDROXYMETHYL)-GAMMA-BUTYROLACTONE WITH ALKALI METAL OR QUATERNARY AMMONIUM ALKOXIDE IN ETHER | SYNGENTA LIMITED (GB) | 2002-07-02 | — | — | US | disclosed |
| EP-1080085-A1 | PREPARATION OF CIS-6,6-DIMETHYL-3-OXA-BICYCLO 3.1.0]HEXAN-2-ONE | ZENECA LIMITED (GB) | 2001-03-07 | — | — | EP | disclosed |
| WO-1999054324-A1 | PREPARATION OF CIS-6,6-DIMETHYL-3-OXA-BICYCLO[3.1.0]HEXAN-2-ONE | ZENECA LIMITED (GB) | 1999-10-28 | — | — | WO | disclosed |
| EP-0031932-B1 | SUBSTITUTED LACTONES, PENTANOIC ACID DERIVATIVES AND PROCESS FOR THEIR PREPARATION | HÜLS TROISDORF AKTIENGESELLSCHAFT (DE) | 1987-07-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020161244-A1 | Preparation of cis-6,6-dimethyl-3-oxa-bicyclo(3.1.0)hexan-2-one | MSMO1, CYP2B6, CYP2D6 | TSHR 4813/4885HSD17B10 208/4885MGAM 750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.